228 related articles for article (PubMed ID: 24237691)
21. Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy.
Farrell LJ; Waters AM; Boschen MJ; Hattingh L; McConnell H; Milliner EL; Collings N; Zimmer-Gembeck M; Shelton D; Ollendick TH; Testa C; Storch EA
Depress Anxiety; 2013 Aug; 30(8):723-31. PubMed ID: 23722990
[TBL] [Abstract][Full Text] [Related]
22. Transdiagnostic Internet treatment for anxiety disorders: A randomized controlled trial.
Titov N; Andrews G; Johnston L; Robinson E; Spence J
Behav Res Ther; 2010 Sep; 48(9):890-9. PubMed ID: 20561606
[TBL] [Abstract][Full Text] [Related]
23. Cannabidiol enhancement of exposure therapy in treatment refractory patients with phobias: study protocol of a randomized controlled trial.
van der Flier FE; Kwee CMB; Cath DC; Batelaan NM; Groenink L; Duits P; van der Veen DC; van Balkom AJLM; Baas JMP
BMC Psychiatry; 2019 Feb; 19(1):69. PubMed ID: 30760241
[TBL] [Abstract][Full Text] [Related]
24. Enhancing exposure therapy for anxiety disorders with glucocorticoids: from basic mechanisms of emotional learning to clinical applications.
Bentz D; Michael T; de Quervain DJ; Wilhelm FH
J Anxiety Disord; 2010 Mar; 24(2):223-30. PubMed ID: 19962269
[TBL] [Abstract][Full Text] [Related]
25. Endogenous in-session cortisol during exposure therapy predicts symptom improvement: Preliminary results from a scopolamine-augmentation trial.
Kuhlman KR; Treanor M; Imbriano G; Craske MG
Psychoneuroendocrinology; 2020 Jun; 116():104657. PubMed ID: 32244170
[TBL] [Abstract][Full Text] [Related]
26. Effects of acute exercise on fear extinction in rats and exposure therapy in humans: Null findings from five experiments.
Jacquart J; Roquet RF; Papini S; Powers MB; Rosenfield D; Smits JAJ; Monfils MH
J Anxiety Disord; 2017 Aug; 50():76-86. PubMed ID: 28618306
[TBL] [Abstract][Full Text] [Related]
27. Exposure therapy, D-cycloserine, and functional magnetic resonance imaging in patients with snake phobia: a randomized pilot study.
Nave AM; Tolin DF; Stevens MC
J Clin Psychiatry; 2012 Sep; 73(9):1179-86. PubMed ID: 23059145
[TBL] [Abstract][Full Text] [Related]
28. Sertraline in children and adolescents with social anxiety disorder: an open trial.
Compton SN; Grant PJ; Chrisman AK; Gammon PJ; Brown VL; March JS
J Am Acad Child Adolesc Psychiatry; 2001 May; 40(5):564-71. PubMed ID: 11349701
[TBL] [Abstract][Full Text] [Related]
29. Psychotherapy in the overall management strategy for social anxiety disorder.
Shear MK; Beidel DC
J Clin Psychiatry; 1998; 59 Suppl 17():39-46. PubMed ID: 9811429
[TBL] [Abstract][Full Text] [Related]
30. Sleep quality predicts treatment outcome in CBT for social anxiety disorder.
Zalta AK; Dowd S; Rosenfield D; Smits JA; Otto MW; Simon NM; Meuret AE; Marques L; Hofmann SG; Pollack MH
Depress Anxiety; 2013 Nov; 30(11):1114-20. PubMed ID: 24038728
[TBL] [Abstract][Full Text] [Related]
31. A prospective examination of predictors of post-event processing following videotaped exposures in group cognitive behavioural therapy for individuals with social phobia.
Laposa JM; Rector NA
J Anxiety Disord; 2011 May; 25(4):568-73. PubMed ID: 21330099
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of the trial-based thought record, a new cognitive therapy strategy designed to change core beliefs, in social phobia.
de Oliveira IR; Powell VB; Wenzel A; Caldas M; Seixas C; Almeida C; Bonfim T; Grangeon MC; Castro M; Galvão A; de Oliveira Moraes R; Sudak D
J Clin Pharm Ther; 2012 Jun; 37(3):328-34. PubMed ID: 21955037
[TBL] [Abstract][Full Text] [Related]
33. The cost-effectiveness of short-term psychodynamic psychotherapy and solution-focused therapy in the treatment of depressive and anxiety disorders during a one-year follow-up.
Maljanen T; Paltta P; Harkanen T; Virtala E; Lindfors O; Laaksonen MA; Knekt P;
J Ment Health Policy Econ; 2012 Mar; 15(1):13-23. PubMed ID: 22611089
[TBL] [Abstract][Full Text] [Related]
34. Attention bias dynamics and symptom severity during and following CBT for social anxiety disorder.
Davis ML; Rosenfield D; Bernstein A; Zvielli A; Reinecke A; Beevers CG; Koster EH; Smits JA
J Consult Clin Psychol; 2016 Sep; 84(9):795-802. PubMed ID: 27362791
[TBL] [Abstract][Full Text] [Related]
35. Enhancing exposure therapy for anxiety disorders, obsessive-compulsive disorder and post-traumatic stress disorder.
McGuire JF; Lewin AB; Storch EA
Expert Rev Neurother; 2014 Aug; 14(8):893-910. PubMed ID: 24972729
[TBL] [Abstract][Full Text] [Related]
36. Agoraphobia: relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine.
Mavissakalian M; Michelson L
J Clin Psychiatry; 1986 Mar; 47(3):117-22. PubMed ID: 3512534
[TBL] [Abstract][Full Text] [Related]
37. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care.
King M; Sibbald B; Ward E; Bower P; Lloyd M; Gabbay M; Byford S
Health Technol Assess; 2000; 4(19):1-83. PubMed ID: 11086269
[TBL] [Abstract][Full Text] [Related]
38. Social anxiety and fear of negative evaluation: construct validity of the BFNE-II.
Carleton RN; Collimore KC; Asmundson GJ
J Anxiety Disord; 2007; 21(1):131-41. PubMed ID: 16675196
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions.
Otto MW; Kredlow MA; Smits JAJ; Hofmann SG; Tolin DF; de Kleine RA; van Minnen A; Evins AE; Pollack MH
Biol Psychiatry; 2016 Aug; 80(4):274-283. PubMed ID: 26520240
[TBL] [Abstract][Full Text] [Related]
40. Treatment of anxiety, tension and restlessness states with Kava special extract WS 1490 in general practice: a randomized placebo-controlled double-blind multicenter trial.
Gastpar M; Klimm HD
Phytomedicine; 2003 Nov; 10(8):631-9. PubMed ID: 14692723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
